A Study to Assess NEU-627 in Healthy Participants

计划入组 74 人 · 首次发布于 2025 年 3 月 28 日

A Study to Assess NEU-111 in Healthy Participants

计划入组 64 人 · 首次发布于 2024 年 7 月 15 日

A Study to Assess NEU-411 in Healthy Participants

计划入组 147 人 · 首次发布于 2023 年 3 月 6 日

NEU-1053

Neu-164

NEU-1017

Neuren Pharmaceuticals Ltd

NYU LANGONE HEALTH

United States

Axcella Health

United States

Cedars-Sinai Partners with Oxford Science Enterprises to Advance Digital Health Innovation, Invests $2M in AI-Powered Neurology Platform

EMA Grants Orphan Drug Designation to Neurenati's NEU-001 for Hirschsprung Disease Treatment

FDA Grants Dual Designations to NEU-001 for Hirschsprung Disease, Offering Hope for Non-Surgical Treatment